Online citations, reference lists, and bibliographies.
← Back to Search

Hyaluronan, A Beneficial Glycosaminoglycan That May Affect The Phenotype Of Cardiac Hypertrophy – A Hypothesis

U. Hellman
Published 2014 · Biology

Cite This
Download PDF
Analyze on Scholarcy
Share
Myocardial hypertrophy contribute to ventricular diastolic dysfunction and can lead to heart failure, arrhythmia and even sudden death. It have been shown that during development of hypertrophy the concentration of the glycosaminoglycan hyaluronan increases. The increased concentration correlates to the increased gene expression of fetal and extracellular matrix genes that is associated with cardiac remodeling. Moreover it has been shown that high molecular weight hyaluronan depolarize the membrane potential of cells. The increase of hyaluronan in cardiac hypertrophy could hypothetically affect the resting membrane potential in cardiomyocytes and thus affect the conduction through the heart. Hypothesis. The role of hyaluronan as a molecule adapting the extracellular matrix when the heart is growing could potentially develop to be harmful to cardiomyocyte resting membrane potential and hence contribute to the risk of arrhythmia.
This paper references
10.1161/01.RES.77.2.258
Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy.
T. Yamazaki (1995)
The role of the extracellular matrix in tissue distribution of
H Wiig
Studying the phenotypes resulting from hyaluronidase defiency - what have we learned ? 8 th International Conference on Hyaluronan
B Triggs-Raine (2010)
10.1074/jbc.274.35.25085
Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties*
N. Itano (1999)
10.1369/0022155415576542
Hyaluronan
R. Hull (2015)
10.1155/2012/893947
Chain Gangs: New Aspects of Hyaluronan Metabolism
Michael Erickson (2012)
10.1016/S0945-053X(01)00186-X
CD44-mediated uptake and degradation of hyaluronan.
W. Knudson (2002)
10.1371/journal.pone.0014393
Growth Factor PDGF-BB Stimulates Cultured Cardiomyocytes to Synthesize the Extracellular Matrix Component Hyaluronan
U. Hellman (2010)
10.1016/S0065-230X(08)60101-3
CD44: structure, function, and association with the malignant process.
D. Naor (1997)
10.1172/JCI10272
Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme.
T. Camenisch (2000)
10.1007/s00441-007-0562-8
Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat
U. Hellman (2007)
10.1021/JA01636A010
The Structure of Hyalobiuronic Acid and of Hyaluronic Acid from Umbilical Cord1,2
B. Weissmann (1954)
beta Blockade after myocardial infarction: systematic review and meta regression analysis.
N. Freemantle (1999)
10.2310/6650.2004.12324
THE FEDERATION OF AMERICAN SOCIETIES FOR EXPERIMENTAL BIOLOGY.
W. J. Meek
10.1253/CIRCJ.CJ-09-0140
Clinical impact of atrial fibrillation in patients with hypertrophic cardiomyopathy. Results from Kochi RYOMA Study.
T. Kubo (2009)
10.1007/978-1-4613-0881-2_10
Glycosaminoglycans in Morphogenesis
B. Toole (1981)
10.1007/s10741-007-9034-1
Return to the fetal gene program protects the stressed heart: a strong hypothesis
Mitra Rajabi (2007)
10.1074/jbc.R700036200
Hyaluronan Synthases: A Decade-plus of Novel Glycosyltransferases*
P. Weigel (2007)
State-of-the-Art Prevention of Heart Failure: Maladaptive versus Adaptive Hypertrophy.
G. Condorelli (2008)
Studying the phenotypes resulting from hyaluronidase defiency -what have we learned? 8th International Conference on Hyaluronan
B Triggs-Raine (2010)
10.1016/S0735-1097(98)00407-0
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death.
A. W. Haider (1998)
10.1016/S0006-291X(02)00558-2
The hyaluronan receptor for endocytosis (HARE) is not CD44 or CD54 (ICAM-1).
J. A. Weigel (2002)
The role of the extracellular matrix in tissue distribution of macromolecules in normal and pathological tissues: potential therapeutic consequences. Microcirculation
H Wiig (2008)
10.1016/j.ygeno.2010.04.003
Temporal correlation between transcriptional changes and increased synthesis of hyaluronan in experimental cardiac hypertrophy.
U. Hellman (2010)
10.1078/0171-9335-00392
Hyaluronan catabolism: a new metabolic pathway.
R. Stern (2004)
10.3909/RICM0546
Medical management of hypertrophic cardiomyopathy.
J. Naghi (2010)
10.1007/978-1-4615-3770-0_10
Proteoglycans and Hyaluronan in Morphogenesis and Differentiation
B. Toole (1991)
10.1016/J.EJCB.2006.05.009
Hyaluronan fragments: an information-rich system.
R. Stern (2006)
10.1006/JMCC.1999.0934
Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes.
P. Lijnen (1999)
10.1006/SCDB.2000.0244
Hyaluronan in morphogenesis.
B. Toole (1997)
The hyaluronan receptor, CD44. Science of Hyaluronan Today
W Knudson (2004)
10.1016/S0945-053X(01)00184-6
Hyaluronan and its catabolic products in tissue injury and repair.
P. Noble (2002)
10.1007/s11892-012-0297-0
The Role of Hyaluronan and the Extracellular Matrix in Islet Inflammation and Immune Regulation
P. Bollyky (2012)
10.1016/J.TIBS.2004.09.002
The biochemical response of the heart to hypertension and exercise.
T. Wakatsuki (2004)
THE POLYSACCHARIDE OF THE VITREOUS HUMOR
K. Meyer (1934)
10.1161/01.RES.0000200177.53882.C3
Early growth response-1 in cardiovascular pathobiology.
L. Khachigian (2006)
10.1038/ICB.1996.32
The structure and function of hyaluronan: An overview.
T. Laurent (1996)
10.1080/10739680701671105
The Role of the Extracellular Matrix in Tissue Distribution of Macromolecules in Normal and Pathological Tissues: Potential Therapeutic Consequences
H. Wiig (2008)
Studying the phenotypes resulting from hyaluronidase defiency - what have we learned
B Triggs-Raine (2010)
Untersuchungen der protein - substanzen in den lichtbrechenden Medier des Auges
CT Mörner (1894)
10.1038/sj.bjp.0702488
Molecular analysis of the Na+ channel blocking actions of the novel class I anti‐arrhythmic agent RSD 921
M. Pugsley (1999)
10.1002/jcb.22772
Depolarization of the membrane potential by hyaluronan
D. Hagenfeld (2010)
The hyaluronan receptor , CD 44 . Science of Hyaluronan Today
W Knudson
10.1152/PHYSREV.1978.58.1.255
Physiological function of connective tissue polysaccharides.
W. Comper (1978)
10.1152/AJPHEART.00385.2002
Relationship between lymph and tissue hyaluronan in skin and skeletal muscle.
Shayn E Armstrong (2002)
10.1016/S0140-6736(10)61217-2
β blockers in hypertension
J. Cruickshank (2010)
10.1152/PHYSREV.00025.2003
Basic mechanisms of cardiac impulse propagation and associated arrhythmias.
A. Kléber (2004)
Untersuchungen der proteinsubstanzen in den lichtbrechenden Medier des Auges
CT Mörner (1894)
10.1016/j.amjcard.2010.08.023
Beta-blockers in hypertension.
C. Ram (2010)
10.1097/HJH.0b013e328340d787
Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy
E. Frohlich (2011)
10.1016/S0022-2828(08)80013-2
Molecular mechanism of cardiac cellular hypertrophy by mechanical stress.
T. Yamazaki (1995)
10.1016/j.semcancer.2008.03.015
Involvement of CD44, a molecule with a thousand faces, in cancer dissemination.
D. Naor (2008)
Beta blockers in hypertension.
F. Zacharias (1973)
Hyaluronan. FASEB journal : official publication of the Federation of American Societies for Experimental Biology
TC Laurent (1992)
Glycosaminoglycans in morphogenesis In: Hay E, editor
Bp Toole (1981)
Medical management of hypertrophic cardiomyopathy. Reviews in cardiovascular medicine
Jj Naghi (2010)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar